OA17444A

OA17444A - Vaccins contre le paludisme gestationnel.

Vaccins contre le paludisme gestationnel. Download PDF

Info

Publication number: OA17444A
Authority: OA; OAPI
Prior art keywords: région; dbl2x; var2csa; sequence; protein
Prior art date: 2013-01-21

Application number

OA1201500287

Other languages

English (en)

Inventor

Nicaise Tuikue Ndam

Philippe Deloron

Justin DORITCHAMOU

Original Assignee

Institut De Recherche Pour Le Developpement (Ird)

Priority date

2013-01-21

Filing date

2014-01-21

Publication date

2016-12-22

2014-01-21 Application filed by Institut De Recherche Pour Le Developpement (Ird) filed Critical Institut De Recherche Pour Le Developpement (Ird)

2016-12-22 Publication of OA17444A publication Critical patent/OA17444A/fr

Links

201000004792 malaria Diseases 0.000 title claims abstract description 56
229960005486 vaccines Drugs 0.000 title abstract description 63
102000004169 proteins and genes Human genes 0.000 claims abstract description 87
108090000623 proteins and genes Proteins 0.000 claims abstract description 87
229920001184 polypeptide Polymers 0.000 claims abstract description 70
230000003071 parasitic Effects 0.000 claims abstract description 44
241000223960 Plasmodium falciparum Species 0.000 claims abstract description 34
101700002612 FCR3 Proteins 0.000 claims description 50
229920000453 Consensus sequence Polymers 0.000 claims description 25
239000000203 mixture Substances 0.000 abstract description 92
229920000023 polynucleotide Polymers 0.000 abstract description 44
239000002157 polynucleotide Substances 0.000 abstract description 44
230000035935 pregnancy Effects 0.000 abstract description 22
230000002163 immunogen Effects 0.000 abstract description 15
230000000875 corresponding Effects 0.000 abstract description 9
230000002265 prevention Effects 0.000 abstract 1
102000004965 antibodies Human genes 0.000 description 43
108090001123 antibodies Proteins 0.000 description 43
229920003013 deoxyribonucleic acid Polymers 0.000 description 33
108020001507 fusion proteins Proteins 0.000 description 32
102000037240 fusion proteins Human genes 0.000 description 32
230000002401 inhibitory effect Effects 0.000 description 28
102000004851 Immunoglobulin G Human genes 0.000 description 26
108090001095 Immunoglobulin G Proteins 0.000 description 26
244000045947 parasites Species 0.000 description 26
PNOCSDIJELBTOO-BHQNPOKRSA-D (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5R,6R)-3-acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2S,3R,4R,5R,6R)-3-acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2S,3R,4R,5R,6R)-3-acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2S,3R,4R,5R,6R)-3-acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O[C@H]8[C@@H]([C@@H](O[C@H]9[C@@H]([C@@H](O)[C@H](O)[C@H](O9)C([O-])=O)O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O8)NC(C)=O)[C@H](O7)C([O-])=O)O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O6)NC(C)=O)[C@H](O5)C([O-])=O)O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O4)NC(C)=O)[C@H](O3)C([O-])=O)O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O2)NC(C)=O)[C@@H](C([O-])=O)O1 PNOCSDIJELBTOO-BHQNPOKRSA-D 0.000 description 21
210000004027 cells Anatomy 0.000 description 20
241000224016 Plasmodium Species 0.000 description 16
150000007523 nucleic acids Chemical group 0.000 description 15
230000014509 gene expression Effects 0.000 description 14
229920001850 Nucleic acid sequence Polymers 0.000 description 13
230000035492 administration Effects 0.000 description 13
241000282414 Homo sapiens Species 0.000 description 12
239000000427 antigen Substances 0.000 description 10
108091007172 antigens Proteins 0.000 description 10
102000038129 antigens Human genes 0.000 description 10
230000004927 fusion Effects 0.000 description 10
238000000338 in vitro Methods 0.000 description 9
238000002255 vaccination Methods 0.000 description 9
229920000160 (ribonucleotides)n+m Polymers 0.000 description 8
230000003053 immunization Effects 0.000 description 8
239000003981 vehicle Substances 0.000 description 7
101710042131 GCG Proteins 0.000 description 6
102100003818 GCG Human genes 0.000 description 6
231100000765 Toxin Toxicity 0.000 description 6
201000009910 diseases by infectious agent Diseases 0.000 description 6
230000001939 inductive effect Effects 0.000 description 6
238000000034 method Methods 0.000 description 6
230000001681 protective Effects 0.000 description 6
239000003053 toxin Substances 0.000 description 6
108020003112 toxins Proteins 0.000 description 6
210000004369 Blood Anatomy 0.000 description 5
210000002826 Placenta Anatomy 0.000 description 5
241000700605 Viruses Species 0.000 description 5
239000008280 blood Substances 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
230000018109 developmental process Effects 0.000 description 5
238000002649 immunization Methods 0.000 description 5
230000003169 placental Effects 0.000 description 5
239000000243 solution Substances 0.000 description 5
230000035897 transcription Effects 0.000 description 5
229920002676 Complementary DNA Polymers 0.000 description 4
TWSALRJGPBVBQU-PKQQPRCHSA-N Glucagon-like peptide 2 Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O)[C@@H](C)CC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)CC)C1=CC=CC=C1 TWSALRJGPBVBQU-PKQQPRCHSA-N 0.000 description 4
241000283973 Oryctolagus cuniculus Species 0.000 description 4
230000000240 adjuvant Effects 0.000 description 4
239000002671 adjuvant Substances 0.000 description 4
150000001413 amino acids Chemical class 0.000 description 4
230000027455 binding Effects 0.000 description 4
238000004166 bioassay Methods 0.000 description 4
239000002299 complementary DNA Substances 0.000 description 4
238000000605 extraction Methods 0.000 description 4
108091022076 maltose binding proteins Proteins 0.000 description 4
239000000463 material Substances 0.000 description 4
108020003175 receptors Proteins 0.000 description 4
102000005962 receptors Human genes 0.000 description 4
239000000126 substance Substances 0.000 description 4
241000283690 Bos taurus Species 0.000 description 3
108010041986 DNA Vaccines Proteins 0.000 description 3
241000255925 Diptera Species 0.000 description 3
101710019325 GDI2185 Proteins 0.000 description 3
102000004547 Glucosylceramidase Human genes 0.000 description 3
108010017544 Glucosylceramidase Proteins 0.000 description 3
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 3
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 3
210000000987 Immune System Anatomy 0.000 description 3
210000003491 Skin Anatomy 0.000 description 3
230000003321 amplification Effects 0.000 description 3
230000000181 anti-adherence Effects 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
230000002068 genetic Effects 0.000 description 3
230000028993 immune response Effects 0.000 description 3
239000007924 injection Substances 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000006011 modification reaction Methods 0.000 description 3
238000003199 nucleic acid amplification method Methods 0.000 description 3
108020004707 nucleic acids Proteins 0.000 description 3
239000002245 particle Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
230000001225 therapeutic Effects 0.000 description 3
210000003812 trophozoites Anatomy 0.000 description 3
-1 β-galactosîdase Proteins 0.000 description 3
DTHNMHAUYICORS-KTKZVXAJSA-N 107444-51-9 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 2
102000002260 Alkaline Phosphatase Human genes 0.000 description 2
108020004774 Alkaline Phosphatase Proteins 0.000 description 2
102100006400 CSF2 Human genes 0.000 description 2
OSGAYBCDTDRGGQ-UHFFFAOYSA-L Calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
101700024131 EXE4 Proteins 0.000 description 2
210000003743 Erythrocytes Anatomy 0.000 description 2
HTQBXNHDCUEHJF-XWLPCZSASA-N Exendin-4 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 2
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
241000282412 Homo Species 0.000 description 2
102000002265 Human Growth Hormone Human genes 0.000 description 2
108010000521 Human Growth Hormone Proteins 0.000 description 2
239000000854 Human Growth Hormone Substances 0.000 description 2
241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
102100015972 IL2 Human genes 0.000 description 2
229950000038 Interferon alfa Drugs 0.000 description 2
102000003996 Interferon beta Human genes 0.000 description 2
108090000467 Interferon beta Proteins 0.000 description 2
102000006992 Interferon-alpha Human genes 0.000 description 2
108010047761 Interferon-alpha Proteins 0.000 description 2
229960001388 Interferon-beta Drugs 0.000 description 2
108010002350 Interleukin-2 Proteins 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
101700007624 PLB Proteins 0.000 description 2
LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
210000003324 RBC Anatomy 0.000 description 2
239000007759 RPMI Media 1640 Substances 0.000 description 2
241000714474 Rous sarcoma virus Species 0.000 description 2
108010090804 Streptavidin Proteins 0.000 description 2
229940094937 Thioredoxin Drugs 0.000 description 2
239000000654 additive Substances 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
125000002091 cationic group Chemical group 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000034994 death Effects 0.000 description 2
231100000517 death Toxicity 0.000 description 2
102000004419 dihydrofolate reductase family Human genes 0.000 description 2
108020001096 dihydrofolate reductase family Proteins 0.000 description 2
238000009826 distribution Methods 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drugs Drugs 0.000 description 2
230000000694 effects Effects 0.000 description 2
229960001519 exenatide Drugs 0.000 description 2
238000009472 formulation Methods 0.000 description 2
239000005090 green fluorescent protein Substances 0.000 description 2
238000003780 insertion Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
238000007834 ligase chain reaction Methods 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
239000011859 microparticle Substances 0.000 description 2
210000000663 muscle cells Anatomy 0.000 description 2
108060005683 ompA Proteins 0.000 description 2
239000000199 parathyroid hormone Substances 0.000 description 2
230000036961 partial Effects 0.000 description 2
229920000656 polylysine Polymers 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000002829 reduced Effects 0.000 description 2
230000001105 regulatory Effects 0.000 description 2
230000001850 reproductive Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
239000007787 solid Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
102000002933 thioredoxin family Human genes 0.000 description 2
108060008226 thioredoxin family Proteins 0.000 description 2
230000000699 topical Effects 0.000 description 2
230000003612 virological Effects 0.000 description 2
QSLFDILMORXPKP-UHFFFAOYSA-N (3-methylimidazol-3-ium-1-yl)-methylsulfanylphosphinate Chemical compound CSP([O-])(=O)N1C=C[N+](C)=C1 QSLFDILMORXPKP-UHFFFAOYSA-N 0.000 description 1
KPYXMALABCDPGN-HYOZMBHHSA-N (4S)-5-[[(2S)-6-amino-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[2-[[2-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]a Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN)CC1=CC=C(O)C=C1 KPYXMALABCDPGN-HYOZMBHHSA-N 0.000 description 1
HQWQVBJUIIJTRE-LKRNKTNVSA-N 4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide;(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol;5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine;hydron;chloride Chemical compound Cl.CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1.COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC.C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 HQWQVBJUIIJTRE-LKRNKTNVSA-N 0.000 description 1
LUBUTTBEBGYNJN-UHFFFAOYSA-N 4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide;5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine Chemical compound CCC1=NC(N)=NC(N)=C1C1=CC=C(Cl)C=C1.COC1=NC=NC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1OC LUBUTTBEBGYNJN-UHFFFAOYSA-N 0.000 description 1
NALREUIWICQLPS-UHFFFAOYSA-N 7-imino-N,N-dimethylphenothiazin-3-amine;hydrochloride Chemical compound [Cl-].C1=C(N)C=C2SC3=CC(=[N+](C)C)C=CC3=NC2=C1 NALREUIWICQLPS-UHFFFAOYSA-N 0.000 description 1
101710027066 ALB Proteins 0.000 description 1
102100001249 ALB Human genes 0.000 description 1
229940033495 ANTIMALARIALS Drugs 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
241000256186 Anopheles <genus> Species 0.000 description 1
102100012919 BCHE Human genes 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
210000004204 Blood Vessels Anatomy 0.000 description 1
108010053652 Butyrylcholinesterase Proteins 0.000 description 1
229960004015 Calcitonin Drugs 0.000 description 1
102400000113 Calcitonin Human genes 0.000 description 1
108060001064 Calcitonin Proteins 0.000 description 1
102000004040 Capsid Proteins Human genes 0.000 description 1
108090000565 Capsid Proteins Proteins 0.000 description 1
229960003677 Chloroquine Drugs 0.000 description 1
WHTVZRBIWZFKQO-UHFFFAOYSA-N Chloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
229920001287 Chondroitin sulfate Polymers 0.000 description 1
KXKPYJOVDUMHGS-OSRGNVMNSA-N Chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
235000001258 Cinchona calisaya Nutrition 0.000 description 1
241000434299 Cinchona officinalis Species 0.000 description 1
108060002292 DMBT1 Proteins 0.000 description 1
102100017741 DMBT1 Human genes 0.000 description 1
101700032127 ETX1 Proteins 0.000 description 1
101700029730 ETX2 Proteins 0.000 description 1
231100000655 Enterotoxin Toxicity 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N Ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
101700001948 F2R Proteins 0.000 description 1
241000272184 Falconiformes Species 0.000 description 1
102100011343 GLB1 Human genes 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229960002743 Glutamine Drugs 0.000 description 1
102000005720 Glutathione Transferase family Human genes 0.000 description 1
108010070675 Glutathione Transferase family Proteins 0.000 description 1
210000003714 Granulocytes Anatomy 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N HEPES Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
229940088597 Hormone Drugs 0.000 description 1
241000725303 Human immunodeficiency virus Species 0.000 description 1
108090000745 Immune Sera Proteins 0.000 description 1
229920002459 Intron Polymers 0.000 description 1
108020004391 Introns Proteins 0.000 description 1
229920000126 Latex Polymers 0.000 description 1
210000004185 Liver Anatomy 0.000 description 1
101700024341 MSP-2 Proteins 0.000 description 1
241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
210000002540 Macrophages Anatomy 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000713333 Mouse mammary tumor virus Species 0.000 description 1
210000003205 Muscles Anatomy 0.000 description 1
102000003505 Myosin family Human genes 0.000 description 1
108060008487 Myosin family Proteins 0.000 description 1
101700036978 OMP Proteins 0.000 description 1
QMGALPCDHIETLP-SZRPRPAPSA-N OP(O)(O)=O.NC1=NC=NC2=C1NC=N2.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O Chemical compound OP(O)(O)=O.NC1=NC=NC2=C1NC=N2.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O QMGALPCDHIETLP-SZRPRPAPSA-N 0.000 description 1
229920000272 Oligonucleotide Polymers 0.000 description 1
229940092253 Ovalbumin Drugs 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
101710043203 P23p89 Proteins 0.000 description 1
101700013868 PSBO2 Proteins 0.000 description 1
208000006551 Parasitic Disease Diseases 0.000 description 1
102000003982 Parathyroid hormone Human genes 0.000 description 1
108090000445 Parathyroid hormone Proteins 0.000 description 1
241000237988 Patellidae Species 0.000 description 1
210000002381 Plasma Anatomy 0.000 description 1
230000036908 Plasma Stability Effects 0.000 description 1
108010088113 Plasmodium falciparum erythrocyte membrane protein 1 Proteins 0.000 description 1
206010037660 Pyrexia Diseases 0.000 description 1
229960000948 Quinine Drugs 0.000 description 1
108060007198 RSE1 Proteins 0.000 description 1
108010033725 Recombinant Proteins Proteins 0.000 description 1
102000007312 Recombinant Proteins Human genes 0.000 description 1
108060007997 SYF2 Proteins 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
108010055044 Tetanus Toxin Proteins 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
229960002175 Thyroglobulin Drugs 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
229920001949 Transfer RNA Polymers 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H Tricalcium phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
239000003655 absorption accelerator Substances 0.000 description 1
239000002253 acid Substances 0.000 description 1
238000007792 addition Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
229940050528 albumin Drugs 0.000 description 1
229940037003 alum Drugs 0.000 description 1
230000002429 anti-coagulation Effects 0.000 description 1
230000000078 anti-malarial Effects 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
239000003430 antimalarial agent Substances 0.000 description 1
239000011324 bead Substances 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
230000000903 blocking Effects 0.000 description 1
101710023118 btfP Proteins 0.000 description 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
230000001413 cellular Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
230000035606 childbirth Effects 0.000 description 1
229940059329 chondroitin sulfate Drugs 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000001808 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000004163 cytometry Methods 0.000 description 1
230000003247 decreasing Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
101700064522 eaeA Proteins 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
230000013080 embryo development ending in birth or egg hatching Effects 0.000 description 1
230000013144 embryo development ending in seed dormancy Effects 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000002708 enhancing Effects 0.000 description 1
239000000147 enterotoxin Substances 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000003260 fluorescence intensity Methods 0.000 description 1
238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
230000003899 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
239000005556 hormone Substances 0.000 description 1
239000003906 humectant Substances 0.000 description 1
150000003840 hydrochlorides Chemical class 0.000 description 1
230000000521 hyperimmunizing Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
230000003308 immunostimulating Effects 0.000 description 1
230000000749 insecticidal Effects 0.000 description 1
239000002917 insecticide Substances 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
238000009114 investigational therapy Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000004816 latex Substances 0.000 description 1
239000003446 ligand Substances 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
210000004962 mammalian cells Anatomy 0.000 description 1
239000002609 media Substances 0.000 description 1
239000004530 micro-emulsion Substances 0.000 description 1
108091005593 modified peptides Proteins 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
101700027202 msp-3 Proteins 0.000 description 1
230000035772 mutation Effects 0.000 description 1
238000007857 nested PCR Methods 0.000 description 1
230000003000 nontoxic Effects 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
239000003921 oil Substances 0.000 description 1
210000000056 organs Anatomy 0.000 description 1
238000004091 panning Methods 0.000 description 1
229960001319 parathyroid hormone Drugs 0.000 description 1
230000001717 pathogenic Effects 0.000 description 1
244000052769 pathogens Species 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
229920002704 polyhistidine Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
230000002516 postimmunization Effects 0.000 description 1
230000002335 preservative Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
238000009117 preventive therapy Methods 0.000 description 1
230000000069 prophylaxis Effects 0.000 description 1
238000003753 real-time PCR Methods 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
108091007521 restriction endonucleases Proteins 0.000 description 1
238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
230000001568 sexual Effects 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
239000008247 solid mixture Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
241000894007 species Species 0.000 description 1
230000002269 spontaneous Effects 0.000 description 1
239000010959 steel Substances 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
238000005670 sulfation reaction Methods 0.000 description 1
230000002194 synthesizing Effects 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
229940118376 tetanus toxin Drugs 0.000 description 1
108010016054 tissue-factor-pathway inhibitor 2 Proteins 0.000 description 1
230000002588 toxic Effects 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
239000011778 trisodium citrate Substances 0.000 description 1
229960001005 tuberculin Drugs 0.000 description 1
238000004450 types of analysis Methods 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
150000003673 urethanes Chemical class 0.000 description 1
239000004034 viscosity adjusting agent Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

OA1201500287 2013-01-21 2014-01-21 Vaccins contre le paludisme gestationnel. OA17444A (fr)